Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Science Behind NMN-A Stable, Reliable NAD+Activator and Anti-Aging Molecule.

Literature DB >> 32549859

The Science Behind NMN-A Stable, Reliable NAD+Activator and Anti-Aging Molecule.

Christopher Shade.

Abstract

Entities: Chemical

Year: 2020 PMID： 32549859 PMCID： PMC7238909

Source DB: PubMed Journal: Integr Med (Encinitas) ISSN： 1546-993X

× No keyword cloud information.

29 in total

1. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.

Authors: Kathryn F Mills; Shohei Yoshida; Liana R Stein; Alessia Grozio; Shunsuke Kubota; Yo Sasaki; Philip Redpath; Marie E Migaud; Rajendra S Apte; Koji Uchida; Jun Yoshino; Shin-Ichiro Imai
Journal: Cell Metab Date: 2016-10-27 Impact factor: 27.287

2. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.

Authors: Juliana Camacho-Pereira; Mariana G Tarragó; Claudia C S Chini; Veronica Nin; Carlos Escande; Gina M Warner; Amrutesh S Puranik; Renee A Schoon; Joel M Reid; Antonio Galina; Eduardo N Chini
Journal: Cell Metab Date: 2016-06-14 Impact factor: 27.287

3. Why NAD(+) Declines during Aging: It's Destroyed.

Authors: Michael B Schultz; David A Sinclair
Journal: Cell Metab Date: 2016-06-14 Impact factor: 27.287

4. In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences.

Authors: Xiao-Hong Zhu; Ming Lu; Byeong-Yeul Lee; Kamil Ugurbil; Wei Chen
Journal: Proc Natl Acad Sci U S A Date: 2015-02-17 Impact factor: 11.205

5. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells.

Authors: Javier R Revollo; Andrew A Grimm; Shin-ichiro Imai
Journal: J Biol Chem Date: 2004-09-20 Impact factor: 5.157

6. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.

Authors: Xiaonan Wang; Xuejun Hu; Yang Yang; Toshihiro Takata; Takashi Sakurai
Journal: Brain Res Date: 2016-04-26 Impact factor: 3.252

Review 7. NAD⁺ Intermediates: The Biology and Therapeutic Potential of NMN and NR.

Authors: Jun Yoshino; Joseph A Baur; Shin-Ichiro Imai
Journal: Cell Metab Date: 2017-12-14 Impact factor: 27.287

Review 8. Interventions to Slow Aging in Humans: Are We Ready?

Authors: Valter D Longo; Adam Antebi; Andrzej Bartke; Nir Barzilai; Holly M Brown-Borg; Calogero Caruso; Tyler J Curiel; Rafael de Cabo; Claudio Franceschi; David Gems; Donald K Ingram; Thomas E Johnson; Brian K Kennedy; Cynthia Kenyon; Samuel Klein; John J Kopchick; Guenter Lepperdinger; Frank Madeo; Mario G Mirisola; James R Mitchell; Giuseppe Passarino; Karl L Rudolph; John M Sedivy; Gerald S Shadel; David A Sinclair; Stephen R Spindler; Yousin Suh; Jan Vijg; Manlio Vinciguerra; Luigi Fontana
Journal: Aging Cell Date: 2015-04-22 Impact factor: 9.304

3. Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain.

Authors: Chidambaram Ramanathan; Thomas Lackie; Drake H Williams; Paul S Simone; Yufeng Zhang; Richard J Bloomer
Journal: Nutrients Date: 2022-01-12 Impact factor: 5.717

3 in total

The Science Behind NMN-A Stable, Reliable NAD+Activator and Anti-Aging Molecule.

1. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.

2. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.

3. Why NAD(+) Declines during Aging: It's Destroyed.

4. In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences.

5. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells.

6. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.

Review 7. NAD⁺ Intermediates: The Biology and Therapeutic Potential of NMN and NR.

Review 8. Interventions to Slow Aging in Humans: Are We Ready?

9. Slc12a8 is a nicotinamide mononucleotide transporter.

10. Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humans.

Review 1. Role of Mitochondria in Retinal Pigment Epithelial Aging and Degeneration.

2. Nicotinamide Mononucleotide Prevents Retinal Dysfunction in a Mouse Model of Retinal Ischemia/Reperfusion Injury.

3. Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain.

Review 7. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR.

Review 8. Interventions to Slow Aging in Humans: Are We Ready?

Review 1. Role of Mitochondria in Retinal Pigment Epithelial Aging and Degeneration.

Review 7. NAD⁺ Intermediates: The Biology and Therapeutic Potential of NMN and NR.